|
Targeting the ALT Pathway to Induce Synthetic Lethality and Treat Poor Outcome Pediatric Tumors |
University of California, Davis |
The ChadTough Defeat DIPG Foundation |
|
Defining the Role of DLST in MYCN-Driven Neuroblastoma |
University of Pennsylvania |
|
|
Exploring Synthetic Lethality of One-Carbon Metabolism Genes and mTORC1 Inhibition in MYCN Amplified Medulloblastoma |
University of California Berkeley |
The Swifty Foundation |
|
Physical Properties of Drug-Resistant Leukemia Cells |
Children’s Hospital Los Angeles |
Cure4Cam Childhood Cancer Foundation |
|
Improving Chemotherapy Experiences for Children with AML |
Drexel University College of Medicine |
|
|
Interrogation of Neuroblastoma Dependencies and RNAs on the Core-Regulatory Circuitry for Therapeutic Inhibition |
St. Jude Children’s Research Hospital |
Northwestern Mutual Foundation |
|
Mechanisms of PAX3-FOXO1 and HES3 Cooperation in Rhabdomyosarcoma |
Nationwide Children’s Hospital |
Flashes of Hope, Tap Cancer Out |
|
Analysis of Unexpected, Potentially Avoidable Admissions to a Pediatric Oncology Unit |
Dartmouth College |
Love Your Melon |
|
Pedi-PRESTO: Pediatric Patient-Reported Symptom Tracking in Oncology |
Children’s Hospital of Philadelphia |
Tap Cancer Out |
|
Mechanisms of PAX3-FOXO1 and HES3 Cooperation in Rhabdomyosarcoma |
Nationwide Children’s Hospital |
Flashes of Hope, Tap Cancer Out |
